MTOR and Parkinson disease: This is consistent with increased levels of mTOR in mouse models of PD (Wills et al., 2012) and the finding that DJ-1 negatively regulates the tumour suppressor PTEN, which is part of the PI3K/AKT signal transduction pathway (Kim et al., 2005).